GCP Audits
At PHARMEXPERT CONSULTANT LLP, our Good Clinical Practice (GCP) Audits provide independent and systematic assessments to ensure clinical trials are conducted ethically, safely, and in full compliance with global regulatory requirements. These audits validate the accuracy of trial data, protect participant rights, and confirm adherence to approved study protocols and standard operating procedures (SOPs).
Our GCP audit and inspection readiness services help pharmaceutical companies proactively prepare for regulatory inspections, minimize risks, and maintain compliance with agencies such as the ICH, FDA, and EMA. By partnering with us, organizations strengthen their quality assurance framework and demonstrate a firm commitment to ethical research and global standards.
Quality Assurance
Ensuring clinical trials maintain the highest standards of quality, data integrity, and ethical conduct.
Regulatory Compliance
Verifying adherence to global regulatory frameworks and local laws governing human subject research.
Risk Management
Identifying potential non-compliance, protocol deviations, and data discrepancies for timely correction.
Continuous Improvement
Offering actionable feedback to enhance clinical trial efficiency and operational excellence.
Key GCP Audit Services
Evaluate site readiness, staff capability, and facility suitability before clinical trial initiation.
Assess investigator performance, documentation accuracy, and protocol adherence during trial conduct.
Ensure participants provide informed, voluntary, and well-documented consent in compliance with ethical standards.
Verify completeness, organization, and compliance of essential trial documents as per regulatory requirements.
Evaluate vendors, CROs, and service providers to confirm compliance with GCP and sponsor expectations.
Review data collection, entry, and analysis processes to ensure accuracy, integrity, and traceability.
Conduct independent reviews of internal systems to maintain continuous compliance and process improvement.
Identify potential non-compliance issues and prepare sites for successful regulatory inspections.